The structural evolution of tau pathological species in the familiar form of FTLD linked to MAPT P301L mutation [150] and recently published data obtained by sensitive biophysical methods reveal a broad conformational range of distinct tau conformers that accompany different phenotypes and also various progression rates in AD. This evidence concerns the gene MAPT and Alzheimer disease.